Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company. We are passionate about finding clever ways to design new medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers. We have a deep pipeline of investigational medicines that we are efficiently advancing in preclinical studies and in intelligently-designed, rigorously-conducted clinical trials. Source
No articles found.
Grifols is a global healthcare company founded in Barcelona in 1909 committed to i...
Grifols is a global healthcare company founded ...
Our mission is to educate and provide an affordable early detection system for the...
Our mission is to educate and provide an afford...
As of June 30, 2019, Sabraâs investment portfolio included 432 real estate prope...
As of June 30, 2019, Sabraâs investment portf...
Motif Bio is a clinical stage biopharmaceutical company developing novel antibioti...
Motif Bio is a clinical stage biopharmaceutical...
NeuBase Therapeutics, Inc. is developing its modular peptide-nucleic acid antisens...
NeuBase Therapeutics, Inc. is developing its mo...
Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its ana...
Neurotrope is a clinical-stage biotech company ...
Precipio has built a platform designed to eradicate the problem of misdiagnosis by...
Precipio has built a platform designed to eradi...
Join the National Investor Network and get the latest information with your interests in mind.